Navigation Links
'Enrichment of Genomic Loci for Targeted Sequencing Application' Is Focus of 2009 AGBT Conference Workshop
Date:1/30/2009

LEXINGTON, Mass., Jan. 30 /PRNewswire/ -- Jeff Olson, Manager of Nucleic Acid Applications, of RainDance Technologies, Inc., will present "Enrichment of Genomic Loci for Targeted Sequencing Applications," to explain application of the RainStorm micro-droplet technology on the new RDT 1000 instrument, at the 2009 Advances in Genome Biology and Technology (AGBT) conference on Friday, February 6th, in Marco Island, Florida.

RainDance Technologies is a provider of innovative microdroplet-based solutions which enable and benefit biological applications utilized in human health and disease research.

"Recent advances in DNA sequencing technologies have improved accuracy and dramatically reduced cost. However, even with the improved efficiency of 'second generation' systems, sequencing thousands of human genomes across various phenotypes is still economically unrealistic. To exploit the full potential of new sequencing techniques, a robust method for isolating biologically relevant genomic loci on the megabase scale will be required," said Olson.

Olson has more than twenty years of experience in molecular biology, technology development and DNA diagnostics. He manages the Nucleic Acids Applications group at RainDance Technologies (www.RainDancetech.com) and is responsible for the development of the company's Sequence Enrichment application.

Olson will present "Enrichment of Genomic Loci for Targeted Sequencing Applications" at the 2009 AGBT meeting on Friday, February 6th, at 2:00 p.m. in the Islands Ballroom at the Marco Island Marriott Resort, Golf Club & Spa, Florida.

The 2009 Advances in Genome Biology and Technology conference (http://www.agbt.org/), a premier scientific forum for capturing the latest advances in new DNA sequencing technologies and for presentations on the applications of genomics to diverse areas in biology and biomedicine, runs February 4-7, 2009.

About RainDance Technologies

RainDance Technologies Inc. is a provider of innovative microdroplet-based solutions for human health and disease research. The speed and simplicity of the company's exciting new technology platform enable researchers to design experiments in ways that were previously unaffordable or unimaginable. The company's RainStorm(TM) technology produces picoliter-volume droplets at a rate of 10 million per hour. Each droplet is the functional equivalent of an individual test tube and can contain a single molecule, reaction, or cell. This versatile technology can adapt proven assays for high-speed workflows with minimize process-induced bias or error.

RainDance's initial application will focus on the targeted sequencing of the human genome --- one of the fastest-growing segments of the $1 billion DNA sequencing market. This application will enable the high-resolution analysis of genetic variation between individuals and populations at a level unmatched by current methodology.

RainDance was founded in 2004 by scientists from Harvard University; the Medical Research Centre in Cambridge, England and the ESPCI in Paris.

For more information, please visit www.RainDancetech.com.

RainStorm(TM) is a trademark of RainDance Technologies, Inc.

Available Topic Expert(s): For information on the listed expert(s), click appropriate link.

Steven Becker

https://profnet.prnewswire.com/Subscriber/ExpertProfile.aspx?ei=78145


'/>"/>
SOURCE RainDance Technologies, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. RainDance Technologies Delivers RDT 1000, Sequence Enrichment Solution to JCVI
2. RainDance Technologies to Present Sequence Enrichment Using Droplet-Based Microfluidics Workshop at ASHG 2008
3. RainDance Technologies to Present Workshop on Sequence Enrichment Using Innovative Microdroplet-Based Solutions at ASHG 2008
4. RainDance Technologies Delivers RDT 1000, Sequence Enrichment Solution to The Genome Center at Washington University School of Medicine in St. Louis
5. The New MACSQuant(TM) Analyzer Combines Cell Enrichment and Flow Cytometry
6. Transgenomic, Inc. Reports Second Quarter 2007 Results
7. Rosetta Genomics Announces Annual General Meeting of Shareholders to be Held on September 24, 2007
8. GeneNews Chief Scientist Dr. C.C. Liew co-editor of new genomics reference book
9. CODA Genomics Announces Issuance of Optimized Synthetic Gene Production Patent
10. Revolutionary Genomics Research Group Opens Boston Office; Provides DNA Evidence in Workers Comp Cases
11. WallSt.net (www.wallst.net) Announces Upcoming Interview With CEO of DNAPrint Genomics
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/22/2017)... ... February 22, 2017 , ... ... addition of Tom Perkins as European director. Operating from Pennside’s Zurich headquarters, Pennside ... , Perkins joins Pennside after more than a decade with leading market ...
(Date:2/22/2017)... N.C., Feb. 22, 2017  United Therapeutics Corporation (NASDAQ: ... results for the fourth quarter and year ended ... results reflect continued growth as net revenues reached ... Martine Rothblatt, Ph.D., United Therapeutics, Chairman and Chief ... to develop and advance our growing product pipeline, ...
(Date:2/21/2017)... Feb. 21, 2017 /PRNewswire/ - SQI Diagnostics Inc. ("SQI" or the ... results for the three months ended December 31, 2016. ... life sciences and diagnostics company that develops and commercializes proprietary ... ... build on the commercial milestones achieved in fiscal 2016," said ...
(Date:2/21/2017)... ... February 21, 2017 , ... ... Liquid Biopsy System , a fully automated benchtop system for collecting intact circulating ... is being launched at the Molecular Medicine Tri Conference (Tri-Con) Annual Meeting 2017 ...
Breaking Biology Technology:
(Date:2/1/2017)... BOSTON, Massachusetts , February 1, 2017 ... and events on emerging technology, announces the availability of a new ... Continue Reading ... ... systems in industrial and collaborative robots. Source: IDTechEx Report "Sensors for ...
(Date:1/30/2017)... --  Invitae Corporation (NYSE: NVTA ), ... announced that it will report its fourth quarter and ... Monday, February 13, 2017, and Invitae,s management team will ... Eastern / 1:45 p.m. Pacific. During ... results, guidance, and recent developments and will spend the ...
(Date:1/26/2017)... DENVER , Jan. 26, 2017  Acuity ... Trends for Biometrics and Digital Identity".  Acuity characterizes ... digital identity when increased adoption reflects a new ... "Biometrics and digital identity are ... says Maxine Most , Principal of Acuity ...
Breaking Biology News(10 mins):